Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric Cancer: An Open-label Randomized Controll Trial

NCT06768463 is registered in ClinicalTrials.gov with University Medical Center Ho Chi Minh City (UMC) as lead sponsor.

NCT NCT06768463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06768463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric Cancer: An Open-label Randomized Controll Trial
Lead sponsor
University Medical Center Ho Chi Minh City (UMC)
Phase
Not applicable
Overall status
Recruiting
Start date
August 1, 2025
Completion date
December 10, 2027
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytoreductive gastrectomy, gastric cancer, metastatic gastric cancer, systemic therapy